- Home
- FULC vs CLPT Comparison
FULC vs CLPT Comparison
Compare FULC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- CLPT
- Stock Information
- Founded
- FULC 2015
- CLPT 1998
- Country
- FULC United States
- CLPT United States
- Employees
- FULC N/A
- CLPT N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- FULC Health Care
- CLPT Health Care
- Exchange
- FULC Nasdaq
- CLPT Nasdaq
- Market Cap
- FULC 372.2M
- CLPT 299.3M
- IPO Year
- FULC 2019
- CLPT N/A
- Fundamental
- Price
- FULC $7.44
- CLPT $10.92
- Analyst Decision
- FULC Buy
- CLPT Strong Buy
- Analyst Count
- FULC 8
- CLPT 3
- Target Price
- FULC $7.13
- CLPT $27.67
- AVG Volume (30 Days)
- FULC 398.4K
- CLPT 261.1K
- Earning Date
- FULC 11-12-2025
- CLPT 11-06-2025
- Dividend Yield
- FULC N/A
- CLPT N/A
- EPS Growth
- FULC N/A
- CLPT N/A
- EPS
- FULC N/A
- CLPT N/A
- Revenue
- FULC N/A
- CLPT $33,593,000.00
- Revenue This Year
- FULC N/A
- CLPT $22.34
- Revenue Next Year
- FULC N/A
- CLPT $25.50
- P/E Ratio
- FULC N/A
- CLPT N/A
- Revenue Growth
- FULC 2752.05
- CLPT 19.68
- 52 Week Low
- FULC $2.32
- CLPT $9.76
- 52 Week High
- FULC $8.50
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- FULC 59.83
- CLPT 52.21
- Support Level
- FULC $6.69
- CLPT $10.31
- Resistance Level
- FULC $7.50
- CLPT $11.13
- Average True Range (ATR)
- FULC 0.40
- CLPT 0.52
- MACD
- FULC 0.07
- CLPT 0.03
- Stochastic Oscillator
- FULC 71.38
- CLPT 60.44
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.